(Press-News.org) A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases. The study was run through NRG Oncology and sponsored by the National Cancer Institute. The results were published on April 22 in JAMA Oncology.
Cancer is traditionally treated with a combined approach, with clinicians using surgery, chemotherapy and radiation therapy to kill and remove cancerous tumors. Systemic treatments such as chemotherapy often are not enough to stop the cancer's growth.
Stereotactic body radiation therapy (SBRT) is a type of radiation therapy that uses precisely targeted beams of very high doses of radiation to destroy tumors. The higher doses are more effective at killing cancer cells than traditional radiation therapy, while the careful targeting of tumors reduces damage to noncancerous tissue.
This approach has been used successfully to treat small, early stage tumors, but until now, it was not clear if such high doses of radiation would be safe in patients with multiple tumors due to metastatic cancer. Because SBRT uses multiple, high-intensity radiation beams, physicians have to be especially careful in locating tumors and targeting the radiation beams to maximize benefits and minimize risks -- a challenge that Steven Chmura, MD, PhD, likened to trying to "cross the beams" in the "Ghostbusters" movie.
"Part of the difficulty is working out the logistics for testing this approach in patients across multiple institutions," said Chmura, Professor of Radiation and Cellular Oncology at UChicago Medicine. "We've thought for a long time that you could treat three or four metastases at the same time, but it's very technically complicated to do so. But before we could test this in something like a large, phase 3 clinical trial, we had to prove that we could get multiple institutions together and come up with a 'cook book' for how to do this right, ensuring that treatment was the same across the board. This was really like seven phase 1 clinical trials rolled into one."
A phase 1 clinical trial, led by Chmura, set out to test the safety of such an approach. In a trial of 39 patients who had breast, prostate or non-small cell lung cancer with at least three metastases or two metastases in close proximity, the investigators determined that there were no treatment-related deaths and that the approach was safe enough to begin phase 2/3 clinical trials in a larger group of patients.
"At the end of the trial, the primary endpoint of six-month dose limiting toxicity was 0%," Chmura said. "This shows us that treating three or four sites of metastases throughout the body with these high-ablative doses of radiotherapy is safe."
Radiation therapy is not without risks. While the study found that no patients experienced side effects severe enough to call off the study, several adverse events were linked to the treatment, including gastric ulcers, broken bones and bone pain, and pneumonitis. In many cases during the four-year trial, these side effects appeared months to years following treatment, highlighting the importance of maintaining long-term follow-up contact with these patients. Overall, however, none of these treatments or side effects led to increased risk of death.
"People have been saying for years that if we used SBRT in patients with multiple, limited metastases, we could potentially cure more patients," said Chmura. "But we needed to conduct these large-scale, phase 2/3 clinical trials to prove that. And before we can do those large trials, we had to set up the infrastructure. The greatest challenge was having a whole team of people come together and figure out how we could define the doses and manage the real-time quality assurance to make sure every single patient had the best treatment possible."
With this collaborative infrastructure in place, the investigators have launched additional trials to test the efficacy of stereotactic body radiation therapy for treating patients with multiple metastases. The group is currently enrolling patients in a phase 2/3 trial for using SBRT for the treatment of metastatic breast cancer, with the goal of treating up to 450 people.
INFORMATION:
The study, "Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases," was supported by NRG Oncology (UG1CA189867, U10CA180868, U10CA180822) and the National Cancer Institute (U24CA180803). Additional authors include Hania Al-Hallaq and Yasmin Hasan of the University of Chicago Medicine, Kathryn Winter and Jennifer Moughan of NRG Oncology, Clifford Robinson of Washington University, Thomas Pisansky and Sean Park of the Mayo Clinic, Virginia Borges of the University of Colorado-Anschutz Medical Center, Martha Matuszak of the University of Michigan, Sun Yi of the University of Arizona Medical Center, Jose Bazan and Julia White of the Ohio State University, Philip Wong of the Centre Hospitalier de L'Universite de Montréal, Harold Yoon of the Heartland Cancer Research National Cancer Institute, Janet Horton and Joseph Salama of the Duke University Medical Center, Gregory Gan of the New Mexico Minority Underserved National Cancer Institute Community Oncology Research Program, Michael Milano of the University of Rochester, and Elin Ruth Sigurdson of the Fox Chase Cancer Center.
About the University of Chicago Medicine & Biological Sciences
The University of Chicago Medicine, with a history dating back to 1927, is one of the nation's leading academic health systems. It unites the missions of the University of Chicago Medical Center, Pritzker School of Medicine and the Biological Sciences Division. Twelve Nobel Prize winners in physiology or medicine have been affiliated with the University of Chicago Medicine. Its main Hyde Park campus is home to the Center for Care and Discovery, Bernard Mitchell Hospital, Comer Children's Hospital and the Duchossois Center for Advanced Medicine. It also has ambulatory facilities in Orland Park, South Loop and River East as well as affiliations and partnerships that create a regional network of care. UChicago Medicine offers a full range of specialty-care services for adults and children through more than 40 institutes and centers including an NCI-designated Comprehensive Cancer Center. Together with Harvey-based Ingalls Memorial, UChicago Medicine has 1,296 licensed beds, nearly 1,300 attending physicians, over 2,800 nurses and about 970 residents and fellows.
Visit UChicago Medicine's health and science news blog at http://www.uchicagomedicine.org/forefront.
Twitter @UChicagoMed
Facebook.com/UChicagoMed
Facebook.com/UChicagoMedComer
PHILADELPHIA--When researchers from Penn Medicine found that many patients with B-cell acute lymphoblastic leukemia (ALL) treated with the investigational chimeric antigen receptor (CAR) T cell therapy targeting the CD22 antigen didn't respond, they went back to the drawing board to determine why. They discovered that less is more when it comes to the length of what is known as the single-chain variable fragment -- the linker that bridges the two halves of the receptor that allows CAR T cells to latch onto tumor cells and attack them.
The findings are reported online today in Nature Medicine.
"A little difference of a few amino acids can make a huge difference for patients," said co-senior author Marco Ruella, MD, an ...
The 'stickiness', or viscosity, of microscopic liquids can now be measured thousands of times faster than ever before, potentially leading to better understanding of living cells, disease diagnostics and pharmaceutical testing.
University of Queensland's Professor Warwick Bowen and his colleagues at the Queensland Quantum Optics Lab developed the world-leading technology, technology that uses lasers to track microscale particles with world-record precision.
"The stickiness, or viscosity, of liquids is incredibly important in biology," Professor Bowen said.
"In living cells, viscosity fluctuations control shape and structure, modulate chemical reactions, and signal whether a cell is healthy or cancerous.
"However, ...
A new study has highlighted that while much is known about the ever increasing uptake of antidepressant medications around the world, there is very little evidence on safe and effective approaches to discontinuing treatment.
In 2020 there were 78 million prescriptions for antidepressants in England and about half of patients treated have taken them for at least two years. Guidelines typically recommend that antidepressants be taken for up to 6 to 12 months after improvement, or for up to two years in people at risk of relapse, but many people take antidepressants for much longer. Surveys of antidepressant users suggest that up to a half of people on long-term antidepressant prescriptions have no clear medical ...
Skeletal muscles enable voluntary movements and are controlled by a special type of neurons called motor neurons, which make direct contact with skeletal muscles through so-called neuromuscular junctions (NMJs). It is through NMJs that skeletal muscles receive signals making them contract or relax. In certain neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), NMJs are destroyed, leading to progressive muscle weakness and ultimately death. Treatments for ALS mainly focus on alleviating symptoms but cannot stop or reverse its disease progression. To find more effective treatments, researchers require accurate and easily accessible lab-based models for ALS to understand its causes and to develop and test new therapies. One step in this ...
Transient grating spectroscopy is an elegant method that uses two laser pulses to activate a medium by creating an interference pattern made of parallel stripes of excitations that can be thermal, electronic, magnetic or even structural. The modulation depth of the pattern and its evolution can be measured by diffracting a third, time-delayed probe beam on the transient grating.
The modulation depth decays as the initial excitation propagates through the material. The distance between the stripes is determined by the wavelength of the pulses used to create the grating, which ...
Researchers at the Paul Scherrer Institute PSI have succeeded for the first time in looking inside materials using the method of transient grating spectroscopy with ultrafast X-rays at SwissFEL. The experiment at PSI is a milestone in observing processes in the world of atoms. The researchers are publishing their research results today in the journal Nature Photonics.
The structures on microchips are becoming ever tinier; hard disks write entire encyclopedias on magnetic disks the size of a fingernail. Many technologies are currently breaking through the boundaries of ...
States with stricter firearms laws reported lower suicide and homicide rates, according to a Rutgers study.
The study, conducted by the New Jersey Gun Violence Research Center, the Rutgers School of Public Health, the Rutgers University-Newark Department of Psychology, the Rutgers School of Criminal Justice, the Rutgers New Jersey Medical School and the Rutgers-Newark Department of Social Work, was published in the Journal of Public Health and examined the association between firearm laws and suicide and homicide rates.
Firearm violence is a major public health concern in the United States, with firearm suicide ...
Irvine, Calif., April 22, 2021 -- California's wildfire problem, fueled by a concurrence of climate change and a heightened risk of human-caused ignitions in once uninhabited areas, has been getting worse with each passing year of the 21st century.
Researchers in the Department of Civil & Environmental Engineering at the University of California, Irvine have conducted a thorough analysis of California Department of Forestry and Fire Protection wildfire statistics from 2000 to 2019, comparing them with data from 1920 to 1999. They learned that the annual burn season has lengthened in the past two decades and that the yearly peak has shifted from August to July. The team's findings are the subject of a study published today in the ...
A minimally invasive retinal reattachment procedure that can be done in an ophthalmologist's office leads to better long-term integrity and structure of the retina's photoreceptors - cells that allow us to see - compared with more invasive operating room procedures, according to new research published April 22.
The study, published in JAMA Ophthalmology and led by researchers at St. Michael's Hospital of Unity Health Toronto, contributes to a growing body of evidence pointing towards pneumatic retinopexy (PnR) as the better first-line retinal reattachment technique to achieve the best visual outcomes.
Retinal detachment is the most common surgical ocular emergency, progressing to loss of vision within hours ...
Chestnut Hill, Mass. (4/22/2021) - Confirming anecdotal evidence that the spread of the coronavirus has strained Americans' mental health, Boston College researchers found reports of anxiety increased to 50 percent and depression to 44 percent by November, 2020 - rates six times higher than 2019 - according to a new report in the journal Translational Behavioral Medicine.
Among U.S. adults aged 18-29, the impact on mental health was even more severe. Rates of anxiety and depression increased to 65 percent and 61 percent, respectively, of the respondents in that age group, according to the report.
Use of prescription medication, counseling services, and unmet need for mental health services also rose significantly, according to the co-authors of the new study, Boston ...
